New Brunswick Public Well being officers have reported “three antagonistic occasions” following influenza immunization.
Public Well being despatched a memo to health-care suppliers stating that the occasions are neurological in nature, and have been reported in adults who acquired the vaccine between Oct. 2 and Oct. 20. The reactions occurred inside seven days of receiving the vaccine.
“Public Well being is conscious of three antagonistic occasions following influenza immunization in New Brunswick reported with one batch of influenza vaccine, all occurring inside 7 days of administration,” mentioned Bruce Macfarlane, a Public Well being spokesperson.
“The severity of those antagonistic occasions are uncommon for New Brunswick.”
The memo asks vaccine suppliers to not use FluLaval Tetra lot #KX9F7, a Glaxo SmithKline product, and that it needs to be stored refrigerated and separated from different merchandise.
In keeping with the memo, the product needs to be labelled “don’t use” till additional discover.
Macfarlane mentioned Public Well being has suggested the Public Well being Company of Canada and Well being Canada and posted an alert on the Canadian Community for Public Well being Intelligence system “to carry consideration to our state of affairs to different jurisdictions.”
Well being Canada is conducting a full evaluation of the state of affairs.
